The Journal of Immunology, Vol 144, Issue 5 1696-1704, Copyright © 1990 by American Association of Immunologists

ARTICLES

Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population

G Pantaleo, S Koenig, M Baseler, HC Lane and AS Fauci
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

This study examines the potential mechanism(s) responsible for the defective clonability of CD8+ T lymphocytes in patients with AIDS. By the combined use of one- and two-color fluorescence cytofluorometry we have shown an increase in the number of circulating DR+ cells due to the expression of DR on a relatively large proportion of T lymphocytes (one-third of CD3+ cells), the majority of them belonging to the CD8+ subset. In addition, the majority of CD8+DR+ cells in AIDS patients did not express CD25 Ag (the receptor for IL-2), a surface marker generally expressed on normal activated T lymphocytes. Sorted CD8+DR+ and CD8+DR- cell populations were analyzed comparatively for their ability to proliferate in response to different stimuli, including anti-CD3, anti- CD2, alone or in combination with anti-CD28 mAb and mitogens such as PHA, alone or in combination with PMA. We have demonstrated that CD8+DR+ cells were severely defective in their proliferative response to triggering via these major pathways of T cell activation even when an exogenous source of IL-2 or IL-4 was added to the microcultures 24 h after initiating the cultures. In contrast, CD8+DR- cells showed a significant proliferation in response to the different stimuli and the proliferative response was strongly enhanced by the addition of IL-2 or IL-4. At the end of the stimulation period CD8+DR+ and CD8+DR- proliferating populations were analyzed for CD25 Ag expression. Only 1 to 10% of CD8+DR+ cells expressed CD25 antigen compared with 40 to 50% of CD8+DR- cells. The proliferative defect of CD8+DR+ cells was further confirmed in experiments performed at the clonal level. The analysis of the frequency of proliferating T lymphocyte-precursors in both CD8+DR+ and CD8+DR- subsets showed that the defective clonogenic potential of CD8+ cells in AIDS patients could be in large part ascribed to CD8+DR+ cells. Five percent of CD8+DR+ cells showed a clonogenic potential compared to the 25% of CD8+DR- cells. Finally, we analyzed the surface expression of VLA-2 Ag, a marker of a chronic state of T cell activation, on circulating T lymphocytes. We have shown that a large proportion of CD3+DR+CD25- cells (50 to 80% in the different patients with AIDS analyzed) expressed VLA-2 Ag.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				L. J. N. Cooper, M. Kalos, D. A. Lewinsohn, S. R. Riddell, and P. D. Greenberg Transfer of Specificity for Human Immunodeficiency Virus Type 1 into Primary Human T Lymphocytes by Introduction of T-Cell Receptor Genes J. Virol., September 1, 2000; 74(17): 8207 - 8212. [Abstract] [Full Text]

				T. L. Whiteside Monitoring of Antigen-Specific Cytolytic T Lymphocytes in Cancer Patients Receiving Immunotherapy Clin. Vaccine Immunol., May 1, 2000; 7(3): 327 - 332. [Full Text] [PDF]

				T. F. Greten, J. E. Slansky, R. Kubota, S. S. Soldan, E. M. Jaffee, T. P. Leist, D. M. Pardoll, S. Jacobson, and J. P. Schneck Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients PNAS, June 23, 1998; 95(13): 7568 - 7573. [Abstract] [Full Text] [PDF]

				A. De Maria, A. Ferraris, M. Guastella, S. Pilia, C. Cantoni, L. Polero, M. C. Mingari, D. Bassetti, A. S. Fauci, and L. Moretta Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions PNAS, September 16, 1997; 94(19): 10285 - 10288. [Abstract] [Full Text] [PDF]

				G. Pantaleo, H. Soudeyns, J. F. Demarest, M. Vaccarezza, C. Graziosi, S. Paolucci, M. Daucher, O. J. Cohen, F. Denis, W. E. Biddison, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection PNAS, September 2, 1997; 94(18): 9848 - 9853. [Abstract] [Full Text] [PDF]

				J. D. Altman, P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis Phenotypic Analysis of Antigen-Specific T Lymphocytes Science, October 4, 1996; 274(5284): 94 - 96. [Abstract] [Full Text]

				C Graziosi, G Pantaleo, K. Gantt, J. Fortin, J. Demarest, O. Cohen, R. Sekaly, and A. Fauci Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals Science, July 8, 1994; 265(5169): 248 - 252. [Abstract] [PDF]

				A. Fauci Multifactorial nature of human immunodeficiency virus disease: implications for therapy Science, November 12, 1993; 262(5136): 1011 - 1018. [Abstract] [PDF]

				L Meyaard, S. Otto, R. Jonker, M. Mijnster, R. Keet, and F Miedema Programmed death of T cells in HIV-1 infection Science, July 10, 1992; 257(5067): 217 - 219. [Abstract] [PDF]